<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Sarepta Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Sarepta Therapeutics, Inc.

    Sarepta Therapeutics is a U.S. commercial-stage biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare neuromuscular diseases. The Company is primarily focused on rapidly advancing the development of its potentially disease-modifying Duchenne muscular dystrophy (DMD) drug candidates. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $96,300,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Douglas S. Ingram
    • FOUNDED
      1980
    • EMPLOYEES
      251-500
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Cassava Sciences, Inc.

    Cassava Sciences, Inc.

    The mission of Cassava Sciences is to detect and treat neurodegenerative diseases,...

    The mission of Cassava Sciences is to detect an...

    Filing Type:    PU
    Fibrocell Science Inc.

    Fibrocell Science Inc.

    Fibrocell is a cell and gene therapy company focused on improving the lives of peo...

    Fibrocell is a cell and gene therapy company fo...

    Filing Type:    PU
    Sorrento Therapeutics, Inc.

    Sorrento Therapeutics, Inc.

    Sorrento’s lead programs with short-term milestones consist of two clinical stag...

    Sorrento’s lead programs with short-term mile...

    Filing Type:    PU
    Alimera Sciences, Inc.

    Alimera Sciences, Inc.

    Alimera Sciences (NASDAQ: ALIM), founded in June 2003, is a pharmaceutical company...

    Alimera Sciences (NASDAQ: ALIM), founded in Jun...

    Filing Type:    PU
    Retrophin, Inc.

    Retrophin, Inc.

    We are a biopharmaceutical company focused on developing our pipeline featuring sp...

    We are a biopharmaceutical company focused on d...

    Filing Type:    PU
    Vaccinex, Inc.

    Vaccinex, Inc.

    Vaccinex is a clinical-stage biotechnology company engaged in the discovery and de...

    Vaccinex is a clinical-stage biotechnology comp...

    Filing Type:    PU
    Audentes Therapeutics, Inc.

    Audentes Therapeutics, Inc.

    Audentes Therapeutics is a leading AAV-based genetic medicines company focused on ...

    Audentes Therapeutics is a leading AAV-based ge...

    Filing Type:    PU
    Scholar Rock Holding Corporation

    Scholar Rock Holding Corporation

    Scholar Rock is a biopharmaceutical company focused on the discovery and developme...

    Scholar Rock is a biopharmaceutical company foc...

    Filing Type:    PU
    Catalyst Pharmaceuticals, Inc.

    Catalyst Pharmaceuticals, Inc.

    Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and ...

    Catalyst Pharmaceuticals is a biopharmaceutical...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.